PT - JOURNAL ARTICLE AU - Dreifuss, David AU - Topolsky, Ivan AU - Icer Baykal, Pelin AU - Beerenwinkel, Niko TI - Tracking SARS-CoV-2 genomic variants in wastewater sequencing data with <em>LolliPop</em> AID - 10.1101/2022.11.02.22281825 DP - 2022 Jan 01 TA - medRxiv PG - 2022.11.02.22281825 4099 - http://medrxiv.org/content/early/2022/11/02/2022.11.02.22281825.short 4100 - http://medrxiv.org/content/early/2022/11/02/2022.11.02.22281825.full AB - During the COVID-19 pandemic, wastewater-based epidemiology has progressively taken a central role as a pathogen surveillance tool. Tracking viral loads and variant outbreaks in sewage offers advantages over clinical surveillance methods by providing unbiased estimates and enabling early detection. However, wastewater-based epidemiology poses new computational research questions that need to be solved in order for this approach to be implemented broadly and successfully. Here, we address the variant deconvolution problem, where we aim to estimate the relative abundances of genomic variants from next-generation sequencing data of a mixed wastewater sample. We introduce LolliPop, a computational method to solve the variant deconvolution problem by simultaneously solving least squares problems and kernel-based smoothing of relative variant abundances from wastewater time series sequencing data. We derive multiple approaches to compute confidence bands, and demonstrate the application of our method to data from the Swiss wastewater surveillance efforts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPart of this study was funded by the Swiss National Science Foundation (grant No. CRSII5_205933). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at https://github.com/cbg-ethz/lollipop